Skip to main content

Neuroprotective Effect of Omega (Nano PSO), Changes in Neurotrophic BDNF and VEGF, and Their Association With Cognitive Status in Patients Who Used to Consume Psychoactive Substances

Phase: NA | Sponsor: Distribuidora Biolife SA de CV | Compound: LSD

Status
recruiting
Institution
Distribuidora Biolife SA de CV
Start date
2024-03-15
End date
2027-03-15
Registry ID
NCT06550167

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.